MeiraGTx Holdings plc(NASDAQ:MGTX) IPO

MeiraGTx Holdings plc(NASDAQ:MGTX) IPO

We are a vertically integrated, clinical stage gene therapy company with four ongoing clinical programs and a broad pipeline of preclinical and research programs. We have core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. Led by an experienced management team, we have taken a portfolio approach by licensing, acquiring and developing technologies that give us depth across both product candidates and indications….

Read More